Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy

References

• AnsariASSanterrePJUludağHBiomaterials for polynucleotide delivery to anchorage-independent cellsJ Mater Chem B2017572387261
   PubMed Web of Science ®Google Scholar
• HeLHannonGJMicroRNAs: small RNAs with a big role in gene regulationNat Rev Genet2004552253115211354
   PubMed Web of Science ®Google Scholar
• GambariRBrognaraESpandidosDAFabbriETargeting oncomiRNAs and mimicking tumor suppressor miRNAs: new trends in the development of miRNA therapeutic strategies in oncologyInt J Oncol20164953227175518
   PubMed Web of Science ®Google Scholar
• LamJKChowMYZhangYLeungSWsiRNA versus miRNA as therapeutics for gene silencingMol Ther Nucleic Acids20154e25226372022
   PubMedGoogle Scholar
• MuthiahMParkI-KChoC-SNanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeuticsExpert Opin Drug Deliv2013101259127323826971
   PubMed Web of Science ®Google Scholar
• Van RooijEKauppinenSDevelopment of microRNA therapeutics is coming of ageEMBO Mol Med2014685186424935956
   PubMed Web of Science ®Google Scholar
• BegMSBrennerAJSachdevJPhase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumorsInvest New Drugs20173518018827917453
   PubMed Web of Science ®Google Scholar
• ReidGKaoSCPavlakisNClinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancerEpigenomics201681079108527185582
   PubMed Web of Science ®Google Scholar
• QuerfeldCPachecoTFossFMPreliminary results of a phase 1 trial evaluating MRG-106, a synthetic microRNA antagonist (LNA antimiR) of microRNA-155, in patients with CTCLBlood2016128182927543436
   PubMed Web of Science ®Google Scholar
• van der ReeMHde VreeJMStelmaFSafety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trialLancet201738970971728087069
   PubMed Web of Science ®Google Scholar
• MengYLiuCZhaoJAn injectable miRNA-activated matrix for effective bone regeneration in vivoJ Mater Chem B2016469426954
   PubMed Web of Science ®Google Scholar
• JiangSZhangH-WLuM-HMicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 geneCancer Res2010703119312720354188
   PubMed Web of Science ®Google Scholar
• IvkovicTCVossGCornellaHCederYmicroRNAs as cancer therapeutics: a step closer to clinical applicationCancer Lett201740711312228412239
   PubMed Web of Science ®Google Scholar
• Van RoosbroeckKFaniniFSetoyamaTCombining anti-miR-155 with chemotherapy for the treatment of lung cancersClin Cancer Res2017232891290427903673
   PubMed Web of Science ®Google Scholar
• WangSLiuZWangLZhangXNF-κB signaling pathway, inflammation and colorectal cancerCell Mol Immunol2009632733419887045
   PubMed Web of Science ®Google Scholar
• Ben-NeriahYKarinMInflammation meets cancer, with NF-[kappa] B as the matchmakerNat Immunol20111271572321772280
   PubMed Web of Science ®Google Scholar
• TongLYuanYWuSTherapeutic microRNAs targeting the NF-kappa B signaling circuits of cancersAdv Drug Deliv Rev20158111525220353
   PubMed Web of Science ®Google Scholar
• BakirtziKHatziapostolouMKaragiannidesINeurotensin receptor 1-microRNA networks modulate colon cancer in humans and miceGastroenterology2011141174921806946
   PubMed Web of Science ®Google Scholar
• ChengCJBahalRBabarIAMicroRNA silencing for cancer therapy targeted to the tumour microenvironmentNature201551810711025409146
   PubMed Web of Science ®Google Scholar
• BabarIAChengCJBoothCJNanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphomaProc Natl Acad Sci U S A2012109E1695E170422685206
   PubMed Web of Science ®Google Scholar
• ZhangMZhouXWangBLactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinomaJ Control Release201316825126123567045
   PubMed Web of Science ®Google Scholar
• BouchouchaMBéliveauÉKleitzFCalonFFortinM-AAntibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targetingJ Mater Chem B2017577217735
   PubMed Web of Science ®Google Scholar
• HeLHuangYChangYA highly selective dual-therapeutic nanosystem for simultaneous anticancer and antiangiogenesis therapyJ Mater Chem B2017582288237
   PubMed Web of Science ®Google Scholar
• WangZWuPHeZMesoporous silica nanoparticles with lactose-mediated targeting effect to deliver platinum (IV) prodrug for liver cancer therapyJ Mater Chem B2017575917597
   PubMed Web of Science ®Google Scholar
• TangFLiLChenDMesoporous silica nanoparticles: synthesis, biocompatibility and drug deliveryAdv Mater2012241504153422378538
   PubMed Web of Science ®Google Scholar
• ZhangJCaiKIntegration of polymers in the pore space of mesoporous nanocarriers for drug deliveryJ Mater Chem B2017588918903
   PubMed Web of Science ®Google Scholar
• SongYLiYXuQLiuZMesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlookInt J Nanomedicine2017128728053526
   PubMed Web of Science ®Google Scholar
• PerikamanaSKMLeeJShinYMOxygen-dependent generation of a graded polydopamine coating on nanofibrous materials for controlling stem cell functionsJ Mater Chem B201758865
   PubMed Web of Science ®Google Scholar
• LeeHDellatoreSMMillerWMMessersmithPBMussel-inspired surface chemistry for multifunctional coatingsScience200731842643017947576
   PubMed Web of Science ®Google Scholar
• ParkJBrustTFLeeHJLeeSCWattsVJYeoYPolydopamine-based simple and versatile surface modification of polymeric nano drug carriersACS Nano201483347335624628245
   PubMed Web of Science ®Google Scholar
• TaghaviSNiaAHAbnousKRamezaniMPolyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cellsInt J Pharm201751630131227840158
   PubMedGoogle Scholar
• ZhuY-JLiW-JHongZTangA-NKongDStable, polyvalent aptamer-conjugated near infrared fluorescent nanocomposite for high-performance cancer cell-targeted imaging and therapyJ Mater Chem B2017592299237
   PubMed Web of Science ®Google Scholar
• HeLZengLMaiXShiCLuoLChenTNucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastomaJ Mater Chem B2017530243034
   PubMed Web of Science ®Google Scholar
• LiLHouJLiuXNucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomasBiomaterials2014353840385024486214
   PubMed Web of Science ®Google Scholar
• LiXYuYJiQQiuLTargeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micellesNanomedicine20151117518425218928
   PubMed Web of Science ®Google Scholar
• DuoYLiYChenCDOX-loaded pH-sensitive mesoporous silica nanoparticles coated with PDA and PEG induce pro-death autophagy in breast cancerRSC Adv201773964139650
   Web of Science ®Google Scholar
• TaoWZengXWuJPolydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effectsTheranostics2016647026941841
   PubMed Web of Science ®Google Scholar
• JurkovicovaDMagyerkovaMKulcsarLmiR-155 as a diagnostic and prognostic marker in hematological and solid malignanciesNeoplasma20146124125124824925
   PubMed Web of Science ®Google Scholar
• HiggsGSlackFThe multiple roles of microRNA-155 in oncogenesisJ Clin Bioinform2013317
   PubMedGoogle Scholar
• ZhouSWangYMengYIn vivo therapeutic success of microRNA-155 antagomir in a mouse model of lupus alveolar hemorrhageArthritis Rheumatol20166895396426556607
   PubMed Web of Science ®Google Scholar
• JiangSZhangLFZhangHWA novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cellsEMBO J2012311985199822354042
   PubMed Web of Science ®Google Scholar
• ThompsonRCVardinogiannisIGilmoreTDIdentification of an NF-κB p50/p65-responsive site in the human MIR155HG promoterBMC Mol Biol2013142424059932
   PubMed Web of Science ®Google Scholar
• GerloffDGrundlerRWurmANF-κB/STAT5/miR-155 network targets PU. 1 in FLT3-ITD-driven acute myeloid leukemiaLeukemia20152953554725092144
   PubMed Web of Science ®Google Scholar
• YangYWangAWeiQHyperbranched Polyglycerol-induced porous silica nanoparticles as drug carriers for cancer therapy in vitro and in vivoChemistryOpen2017615816428168161
   PubMed Web of Science ®Google Scholar
• ZhangBLuoZLiuJDingXLiJCaiKCytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivoJ Control Release201419219220125034575
   PubMed Web of Science ®Google Scholar
• WongRCChowSYZhaoSFongW-PNgDKLoP-CpH-responsive dimeric zinc (II) phthalocyanine in mesoporous silica nanoparticles as an activatable nanophotosensitizing system for photodynamic therapyACS Appl Mater Interfaces20179234872349628661122
   PubMed Web of Science ®Google Scholar
• IqbalZLaiEPAvisTJAntimicrobial effect of polydopamine coating on Escherichia coliJ Mater Chem2012222160821612
   Web of Science ®Google Scholar
• ZhangMZhangXHeXChenLZhangYA self-assembled polydopamine film on the surface of magnetic nanoparticles for specific capture of proteinNanoscale201243141314722535306
   PubMed Web of Science ®Google Scholar
• SongJ-TYangX-QZhangX-SYanD-MWangZ-YZhaoY-DFacile synthesis of gold nanospheres modified by positively charged mesoporous silica, loaded with near-infrared fluorescent dye, for in vivo X-ray computed tomography and fluorescence dual mode imagingACS Appl Mater Interfaces20157172871729726189815
   PubMed Web of Science ®Google Scholar
• PuJBaiDYangXLuXXuLLuJAdrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155Biochem Biophys Res Commun201242821021523036199
   PubMed Web of Science ®Google Scholar
• LiuBLiuYZhaoLUpregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathwayMol Carcinog2017562669268028767179
   PubMed Web of Science ®Google Scholar
• FletcherJIHaberMHendersonMJNorrisMDABC transporters in cancer: more than just drug efflux pumpsNat Rev Cancer20101014715620075923
   PubMed Web of Science ®Google Scholar
• MaY-CWangJ-XTaoWRedox-responsive polyphosphoester-based micellar nanomedicines for overriding chemoresistance in breast cancer cellsACS Appl Mater Interfaces20157263152632526552849
   PubMed Web of Science ®Google Scholar
• BaguleyBCMultiple drug resistance mechanisms in cancerMol Biotechnol20104630831620717753
   PubMed Web of Science ®Google Scholar
• Van RoosbroeckKFaniniFSetoyamaTTargeting miR-155 to resensitize lung cancer to chemotherapyEuropean Journal of Cancer201661S116
   Web of Science ®Google Scholar
• MengXNiuJYangYDownregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cellsInt J Clin Exp Pathol201710213031312
   Web of Science ®Google Scholar
• BayraktarRVan RoosbroeckKmiR-155 in cancer drug resistance and as target for miRNA-based therapeuticsCancer and Metastasis Reviews201837334429282605
   PubMed Web of Science ®Google Scholar